Portfolio

Companies We Back

We invest in a small number of companies at a time, working closely with founders from early science through clinical and commercial milestones.

BiopharmaSeries A

Amber Bio

Pioneering a first-of-its-kind RNA writing platform capable of making multi-kilobase edits across thousands of diverse mutations with a single product — addressing previously undruggable patient populations in genetic medicine.

Work With Us

Building something in Biopharma or Medtech?

We are always looking for the next great company. If you have a compelling idea and differentiated science, we want to hear from you.

Submit a Pitch